Research Alliance Corp. II (RACB): Price and Financial Metrics

Research Alliance Corp. II (RACB): $10.10

0.04 (+0.40%)

POWR Rating

Component Grades








RACB Price/Volume Stats

Current price $10.10 52-week high $10.45
Prev. close $10.06 52-week low $9.64
Day low $10.06 Volume 13,500
Day high $10.45 Avg. volume 187,850
50-day MA $9.92 Dividend yield N/A
200-day MA $9.85 Market Cap 193.79M

RACB Stock Price Chart Interactive Chart >

Research Alliance Corp. II (RACB) Company Bio

Research Alliance Corp. II intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry. The company was incorporated in 2020 and is based in Las Vegas, Nevada.

RACB Latest News Stream

Event/Time News Detail
Loading, please wait...

RACB Latest Social Stream

Loading social stream, please wait...

View Full RACB Social Stream

Latest RACB News From Around the Web

Below are the latest news stories about RESEARCH ALLIANCE CORP II that investors may wish to consider to help them evaluate RACB as an investment opportunity.

Research Alliance Corp. II Will Redeem Public Shares

LAS VEGAS, November 28, 2022--Research Alliance Corp. II (the "Company") (NASDAQ: RACB), a special purpose acquisition company, today announced that, the Company will redeem all of its outstanding shares of Class A Common Stock, par value $0.0001, issued by the Company in its initial public offering (the "Public Shares"), effective as of the close of business on December 2, 2022, if at the Company’s Special Meeting on December 2, 2022 the requisite stockholders of the Company approve (the "Stock

Yahoo | November 28, 2022

Research Alliance Corp. II (NASDAQ:RACB) is definitely on the radar of institutional investors who own 45% of the company

Every investor in Research Alliance Corp. II ( NASDAQ:RACB ) should be aware of the most powerful shareholder groups...

Yahoo | November 7, 2022

Read More 'RACB' Stories Here

RACB Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!